编号/登记号：
NCT00883675
注册时间：
2009-04-20
研究开始时间：
2022-05-09
研究结束时间：
2022-12-12
项目类型：
clinicaltrials临床试验
本院角色：
参与单位
多中心研究：
国际多中心
招募状态：
Completed
试验分期：
Ⅳ期
研究疾病/适应症：
Non-small Cell Lung Cancer
研究类型：
Interventional
研究单位：
[1]Maestro Clinical, Inc.
[2]Dartmouth-Hitchcock Medical Center,Lebanon, New Hampshire, United States, 03756
[3]Beijing Chaoyang Hospital,Beijing, China
[4]Beijing Tumor Hospital,Beijing, China
[5]Beijing Youyi Hospital,Beijing, China
[6]China-Japan Friendship Hospital,Beijing, China
[7]Xuanwu Hospital,Beijing, China
[8]First Affiliated Hospital, Guangzhou Medical College,Guangzhou, China
[9]Sun Yat-sen Cancer Center,Guangzhou, China
[10]Shanghai Chest Hopsital, Pulmonary Medicine,Shanghai, China
[11]Shanghai Lung Cancer Center, Shanghai Chest Hospital,Shanghai, China
[12]Shanghai Pulmonary Hospital,Shanghai, China
[13]Tianjin Cancer Center,Tianjin, China
关键词：
Lung cancer
Adjuvant therapy
研究目的：
The purpose of this study is to determine whether it is safe to treat lung cancer patients who have undergone an attempt at curative resection with the combination of docetaxel and carboplatin.
